Pancreatic NETs: where do we stand now? - Wikidata - awgldk - TriplyDB

Pancreatic NETs: where do we stand now?

Pancreatic NETs: where do we stand now?

http://www.wikidata.org/entity/Q38181004

about

Novel targeted therapies in adrenocortical carcinoma.Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths

P2860

Q37233378-31542C78-2EC9-4EF1-8579-505A6FDB77B6 Q56962802-7CF66533-1E1F-4976-B4CD-75C99ED24AC0

P2860

Pancreatic NETs: where do we stand now?

http://www.wikidata.org/entity/Q38181004

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pancreatic NETs: where do we stand now?

@en

type

label

Pancreatic NETs: where do we stand now?

@en

prefLabel

Pancreatic NETs: where do we stand now?

@en

P1433

Q38181004-D028F03D-74A9-4BC1-A5C6-E59F994665AB

P1476

Q38181004-0419C23F-CD8C-4375-BA7F-62904BF8AB6D

P2093

Q38181004-0A18B4F0-7590-4018-B131-268E556E30DC

Q38181004-1358A408-495B-42FD-86B4-5C7A9811027F

Q38181004-22A01620-B393-4019-94F9-F192EE4AB79F

Q38181004-AEE66004-EC6E-4CF6-83EE-2CF4BEE93738

P2860

Q38181004-0E3F3112-AB40-4756-8DE7-FB84F245EE2B

Q38181004-1F64D407-4CBA-4F96-BBAE-A77970639544

Q38181004-311F2C1A-6E74-4EAB-93BC-D7BB1B7757EE

Q38181004-32F38210-DD9D-4EDD-BEAD-C6768AA82592

Q38181004-3FD764AB-0F22-4080-81CD-DFA539D95A7C

Q38181004-446E7448-5456-400E-9C7F-1BA5671FC7F6

Q38181004-7474C305-989B-4910-A1FA-DE7F03A6C410

Q38181004-8554E6F5-A7C5-46E7-87BD-64477655723D

Q38181004-888D6F5C-6C62-46DE-9570-B3443AD10DDA

Q38181004-92E12D86-8038-476E-BAD2-F85624578FE7

P2888

Q38181004-90692831-25F5-45F4-8B70-18C38BFB0A52

P304

Q38181004-2D91D480-BE1C-4000-92D7-B5B0B6377249

P31

Q38181004-93C01C65-0BD9-413A-91BC-B3FC33B3E01B

P356

Q38181004-FAEA4232-32F2-482F-B641-C44700BAE3AE

P433

Q38181004-82C7B41B-7DB5-4E7C-A96D-A5933EE01FC8

P478

Q38181004-7F55E7D5-2811-4FF7-AB9E-226C217B3599

P50

Q38181004-A038CD19-5B17-44C8-819C-F05C6DB15089

P577

Q38181004-7DE9EBB3-D13D-4E79-9D1D-468825E9A53B

P6179

Q38181004-57EC60DC-BF52-43AD-9785-CC565B5C8138

P698

Q38181004-68E25D79-24F4-4B83-8975-A74F4168E643

P356

S10555-013-9466-0

P1433

Cancer and Metastasis Reviews

P1476

Pancreatic NETs: where do we stand now?

@en

P2093

D Castellano

http://www.w3.org/2001/XMLSchema#string

E González

http://www.w3.org/2001/XMLSchema#string

J Strosberg

http://www.w3.org/2001/XMLSchema#string

R Salazar

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.

FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors.

First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.

P2888

s10555-013-9466-0

P304

361-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-013-9466-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Sandrine Faivre

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021249994

http://www.w3.org/2001/XMLSchema#string

P698

24452757

http://www.w3.org/2001/XMLSchema#string